Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001562180-25-001026

Chief Scientific Officer sold 9,215 shares at an average $30.04 ($276,776)

  • Chief Scientific Officer acquired 9,215 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Russell Alan J Chief Scientific Officer 2025-02-05 Option exercise 10b5-1 +8,015 $0.18 $1,443 22,878 D
Russell Alan J Chief Scientific Officer 2025-02-05 Sale 10b5-1 −8,015 $30.02 $240,623 14,863 D
Russell Alan J Chief Scientific Officer 2025-02-06 Option exercise 10b5-1 +1,200 $0.18 $216 16,063 D
Russell Alan J Chief Scientific Officer 2025-02-06 Sale 10b5-1 −1,200 $30.13 $36,153 14,863 D
Derivatives
Russell Alan J Chief Scientific Officer 2025-02-05 Option exercise · Stock Option (Right to Buy) 10b5-1 −8,015 1,348,765 D
Russell Alan J Chief Scientific Officer 2025-02-06 Option exercise · Stock Option (Right to Buy) 10b5-1 −1,200 1,347,565 D
Open-market sales · 9,215 sh · avg $30.04 · $276,776
Loading xslF345X05/primarydocument.xml…